Clinical trials for rcc
WebJan 3, 2024 · Our clinical trials database has open, closed and result summaries of trials in the UK. What clinical trials are Medical research studies involving people are called … WebSep 13, 2024 · A clinical trial to compare the effectiveness of savolitinib plus durvalumab versus sunitinib in MET-driven (hepatocyte growth factor receptor), unresectable and locally advanced or metastatic PRCC (Papillary Renal Cell Carcinoma) Condition or disease Intervention/treatment
Clinical trials for rcc
Did you know?
WebClinical Trial Page; ... and safety of AK104 in combination with axitinib as a first-line treatment for advanced/metastatic specific subtypes of renal cell carcinoma (ssRCC). … WebMar 20, 2024 · Approaches to Dosing TKIs in Patients with Advanced RCC. EP: 8. COSMIC-313 Trial of Cabozantinib, Nivolumab and Ipilimumab in Frontline Advanced RCC. EP: 9. Phase III Trial of Lenvatinib, Pembrolizumab, and Belzutifan or Quavonlimab in Frontline Advanced RCC. Now Viewing.
WebNov 6, 2024 · A phase 3, randomized, active-controlled trial will evaluate the efficacy and safety of a HIF-2α inhibitor for the second-line treatment of clear cell RCC. WebJan 4, 2024 · This phase III trial compares the usual treatment (treatment with ipilimumab and nivolumab followed by nivolumab alone) to treatment with ipilimumab and nivolumab, followed by nivolumab with cabozantinib in patients with untreated renal cell carcinoma that has spread to other parts of the body.
WebApr 14, 2024 · Lindy G. Durrant, Fayaz Masters, Samantha Paston, Robert Miller, David J. Pinato, Rebecca Herbertson, Anne Armstrong, Stefan Symeonides, Christian Ottensmeier; Abstract CT256: Modi-1, anti-citrullinated neoepitope vaccine alone and combined with checkpoint inhibitors in patients with head and neck, breast, renal and ovarian … WebParticipation in clinical trials should be the primary route by which patients get access to investigational medicines, and contribute to the collection of safety and efficacy data needed to support regulatory approval worldwide. For patients with a serious or life-threatening disease who are ineligible or unable to participate in a clinical ...
WebJun 18, 2024 · A Safety and Efficacy Study Evaluating CTX130 in Subjects With Relapsed or Refractory Renal Cell Carcinoma (COBALT-RCC) ... Contact: Clinical Trials +1 (877) 214-4634: [email protected]: Locations. Layout table for location information; United States, California: Research Site 2:
WebNov 17, 2024 · As we approach the end of 2024, non-clear cell (ncc) histology remains an unmet need in the treatment paradigm for patients with renal cell carcinoma (RCC), Rana R. McKay, MD, said during her discussion at the 38th Annual CFS meeting. 1. “When we look at the outcomes of those with non-clear cell histology, they have a shorter time to ... i couldn\u0027t believe itWebJan 11, 2024 · A Phase 2, Single-arm, Open-label Clinical Trial of Pembrolizumab Plus Lenvatinib in Participants With First-line Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma (nccRCC) (KEYNOTE-B61) Actual Study Start Date : February 23, 2024: Estimated Primary Completion Date : August 16, 2024: Estimated Study Completion … i couldn\u0027t bear it or bare itWebClinical trials are part of clinical research and at the heart of all medical advances. Clinical trials look at new ways to prevent, detect, or treat disease. Researchers also use … i couldn\u0027t believe it was trueWebMay 26, 2010 · Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC) is an inherited type of papillary kidney cancer (it runs in families). Papillary kidney cancer can also occur sporadically, or without a family connection. More research is needed to determine whether treatments for papillary kidney cancer, such as bevacizumab and erlotinib, work … i couldn\u0027t catch thatWebApr 10, 2024 · This study will evaluate the efficacy, safety, and pharmacokinetics of RO7247669 (PD1-LAG3) in combination with axitinib alone or with tiragolumab (anti-TIGIT) and axitinib, as compared to pembrolizumab and axitinib in participants with previously untreated, unresectable locally advanced or metastatic clear-cell renal cell carcinoma … i couldn\u0027t believe it make it affirmativeWebMay 3, 2024 · Post-nephrectomy tumor shows renal cell cancer (RCC) with a predominantly clear cell histology, including participants with sarcomatoid features; Participants must have no clinical or radiological evidence of macroscopic residual disease or distant metastases after nephrectomy; Eastern Cooperative Oncology Group (ECOG) Performance Status … i couldn\u0027t find it meaningWebA One-arm Exploratory Clinical Research Program Study of Apatinib in Advanced Metastatic Renal Cell Carcinoma Patients. Latest version (submitted May 12, 2016) on ClinicalTrials.gov. A study version is represented by a row in the table. Select two study versions to compare. One each from columns A and B. i couldn\u0027t cut the grass because